Xenon Pharmaceuticals shares owned by Rhenman & Partners Asset Management AB
Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by Rhenman & Partners Asset Management AB
from 13F filings
Historical chart of Rhenman & Partners Asset Management AB investment in Xenon Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Xenon Pharmaceuticals held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Xenon Pharmaceuticals by Rhenman & Partners Asset Management AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $1.6M | 28k | 58.15 |
| 2025-12-31 | $6.2M | 139k | 44.82 |
| 2025-09-30 | $3.3M | 81k | 40.15 |
| 2025-06-30 | $1.1M | 35k | 31.30 |
| 2025-03-31 | $1.2M | 35k | 33.55 |
| 2024-12-31 | $1.4M | 35k | 39.20 |
| 2024-09-30 | $1.4M | 35k | 39.37 |
| 2024-06-30 | $1.4M | 35k | 38.99 |
More positions owned by Rhenman & Partners Asset Management AB
View all positions for Rhenman & Partners Asset Management AB